Nocturia Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Projected Growth of the Nocturia Market?
The size of the nocturia market has seen a significant increase in recent years. There will be a rise from $2.87 billion in 2024 to $3.11 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. The growth experienced in the past can be linked to an increasing number of cases of cardiovascular diseases, an upsurge in insomnia cases, an aging population, heightened awareness about nocturia and associated conditions, and a growth in comorbidities.

Expectations are high for significant expansion in the nocturia market in the coming years, with projections indicating a growth to $4.23 billion in 2029, marking a compound annual growth rate (CAGR) of 8.0%. This surge during the forecast period is linked to a rising prevalence of bladder obstruction conditions and urinary tract inflammation. Additionally, an escalation in instances of nocturia, alcohol consumption, increased ingestion of liquids which triggers nocturia, a heightened comprehension of the relationship between nocturia, sleep disorders, kidney health, and aging demographic are all contributing factors. The forecast period also anticipates trends like advancements in diagnostic techniques, the emergence of new medicaments, amplified research, and investment towards nocturia therapies, revolution in surgical and non-surgical treatments and the incorporation of personalized medicine.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21232

What Are the Different Nocturia Market Segments?
The nocturia market covered in this report is segmented -

1) By Drug: Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Other Drugs
2) By Indication: Mixed Nocturia, Low Nocturnal Bladder Capacity, Nocturnal Polyuria, Global Polyuria
3) By Causes: Urological Infection, Tumor Of The bladder, Diuretic Medications, Regular Alcohol Or coffee, Liver infection, Diabetes, Pregnancy, Other Causes
4) By End User: Hospitals, Home Care, Clinics

Subsegments:
1) By Anticholinergic Drugs: Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine
2) By Desmopressin: Intranasal Desmopressin, Oral Desmopressin
3) By Antibiotics: Nitrofurantoin, Trimethoprim, Fosfomycin, Other Antibiotics
4) By Antispasmodic: Hyoscine Butylbromide, Flavoxate, Other Antispasmodics
5) By Other Drugs: Alpha-blockers, Beta-3 Agonists, Diuretics, Other Pharmacological Treatments

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21232&type=smp

What Are the Primary Drivers Shaping the Nocturia Market?
The increasing occurrence of cardiovascular diseases is anticipated to spur the nocturia market's expansion. These forms of illnesses involve a variety of disorders that impact the heart and blood vessels, including conditions like heart disease, stroke, and hypertension. The rising incidence of cardiovascular diseases is linked to factors like aging populations, inactive lifestyles, unhealthy eating habits, smoking, excessive alcohol use, obesity, high blood pressure, high cholesterol, diabetes, and a genetic predisposition. Those affected by cardiovascular diseases frequently exhibit nocturia as a symptom, thus increasing the demand for diagnostic and therapeutic options. With the global rise in cardiovascular issues due to aging populations and unhealthy habits, the necessity for effective management of nocturia is becoming increasingly important. For example, data from the Centers for Disease Control and Prevention, a government agency in the US, showed that in May 2024, heart disease caused 702,880 deaths in 2022, which equates to 20% of all deaths in the US. Every year, around 805,000 people suffer a heart attack, with 605,000 being new cases and 200,000 happening in those with a prior history. Hence, the rising occurrence of cardiovascular diseases is fueling the growth of the nocturia market.

Which Companies Are Leading in the Nocturia Market?
Major companies operating in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc

What Trends Are Expected to Dominate the Nocturia Market in the Next 5 Years?
Companies holding a significant market share in the nocturia industry are advancing their product lines with innovative developments like orally disintegrating tablets (ODTs), to improve ease of use and encourage consistent treatment regime adherence among patients. ODTs, offering a solid dosage that swiftly dissolves in the mouth without the need for water, are particularly beneficial for patients who have trouble swallowing. For example, Adalvo Limited, a pharmaceutical firm from Malta, introduced Desmopressin ODT in Europe during July 2024. This drug is used to treat ailments characterized by excessive fluid loss in the body, including central cranial diabetes insipidus. As a synthetic version of vasopressin, it is effective in controlling conditions such as diabetes insipidus, extreme thirst and urinary frequency, and nocturnal enuresis, as it replicates the actions of the natural hormone and reduces the volume of water that is excreted through urine. It also has applications in controlling bleeding in mild to moderate hemophilia A and von Willebrand disease by stimulating the secretion of clotting factors in the blood.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/nocturia-global-market-report

What Are the Top Revenue-Generating Geographies in the Nocturia Market?
North America was the largest region in the nocturia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nocturia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Nocturia Market?
2. What is the CAGR expected in the Nocturia Market?
3. What Are the Key Innovations Transforming the Nocturia Industry?
4. Which Region Is Leading the Nocturia Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.